Diversifying drug development with a metal catalyst
Researchers have outlined a method of formulating drug-like aliphatic and aromatic carbon-hydrogen scaffolds into drugs using a metal catalyst...
List view / Grid view
Researchers have outlined a method of formulating drug-like aliphatic and aromatic carbon-hydrogen scaffolds into drugs using a metal catalyst...
Study using mass spectrometry-based analysis provides a greater understanding of the cell and a comprehensive map of cell proteins...
The development of a process to recycle pharmaceutical waste products has led to the recovery of aluminum and polyvinyl chloride (PVC) from blister packs...
The artemisinin-based combination therapy (ACT), pyronaridine-artesunate, has been shown to be as effective in treating malaria as other drugs...
Researchers have developed a method using environmentally-friendly water and stable bonding between carbon and manganese instead of highly reactive metals...
Setting specifications for new oral products can be challenging. Too lenient, and there is a risk of passing batches of inadequate quality; too stringent, and there is a risk of rejecting acceptable batches.
A study has found that the prevalence of knee osteoarthritis was significantly lower in participants using hormone therapy than those not taking hormones...
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
A study has found that opioids, including morphine, codeine and fentanyl increase the likelihood of patients being affected by pneumonia...
A complete workflow to quantify intact therapeutic proteins in plasma matrix has been developed, covering three critical components in preclinical sample analysis: target protein enrichment/purification, LC/MS data acquisition and quantitative data analysis.
Ustekinumab has been submitted to be the first interleukin (IL)-12/23 inhibitor licensed for the treatment of ulcerative colitis...
The results of a long-term study on the use of ADHD medication has advised that they are unlikely to result in heart damage, or cardiac difficulties...
Deloitte has found a sharp decline in the returns on investment from top pharmaceutical companies, with returns at almost half of what they were in 2010...
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK...
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...